|
Volumn 126, Issue 51-52, 2001, Pages 1472-1475
|
Atrial fibrillation - Treatment;Vorhofflimmern - Therapie
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
DISOPYRAMIDE;
FLECAINIDE;
HEPARIN;
PHENPROCOUMON;
PROPAFENONE;
QUINIDINE;
SOTALOL;
WARFARIN;
ANTICOAGULANT THERAPY;
CARDIOVERSION;
CHRONIC DISEASE;
CLINICAL TRIAL;
CONTINUING EDUCATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HEART ARRHYTHMIA;
HEART ATRIUM ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HUMAN;
MAJOR CLINICAL STUDY;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
THROMBOEMBOLISM;
ANTI-ARRHYTHMIA AGENTS;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
DISEASE PROGRESSION;
ELECTRIC COUNTERSHOCK;
ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC;
HUMANS;
RECURRENCE;
RISK FACTORS;
THROMBOEMBOLISM;
TIME FACTORS;
VITAMIN K;
|
EID: 0035930864
PISSN: 00120472
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2001-19207 Document Type: Review |
Times cited : (4)
|
References (23)
|